Group One Trading, L.P. Annovis Bio, Inc. Transaction History
Group One Trading, L.P.
- $2.54 Billion
- Q4 2024
A detailed history of Group One Trading, L.P. transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 26,206 shares of ANVS stock, worth $71,804. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,206
Previous 52,767
50.34%
Holding current value
$71,804
Previous $425,000
69.18%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ANVS
# of Institutions
48Shares Held
1.56MCall Options Held
348KPut Options Held
535K-
Vanguard Group Inc Valley Forge, PA466KShares$1.28 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il215KShares$589,6670.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$275,9420.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$272,8050.0% of portfolio
-
Merit Financial Group, LLC98.5KShares$269,9330.01% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $22.4M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...